Avivagen Continues Market Growth with New Customer Win in Western Mexico
• Order signifies important growth in key production territories in Mexico Ottawa, ON / Business Wire/ May 6, 2021 / –Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances feed intake and supports immune function, thereby supporting general health …Read More
Avivagen Announces Recurring Order for OxC-betaTM Livestock
•Largest purchase amount and longest duration purchase to-date •Four tonne per month order secured •Order follows five successful OxC-betaTM Livestock commercial trials conducted with various species over the past six months Ottawa, ON / Business Wire/ May 3, 2021 / Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products …Read More
Avivagen Announces First Purchase Order from Large Integrated Producer in Asia
Ottawa, ON / Business Wire/ April 26, 2021 / – Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and human applications that safely enhances food production and supports immune function, thereby supporting general health and performance, is pleased to announce it has received its …Read More
Avivagen Announces Largest Single Customer Purchase Order
• 4 tonne order is the largest single shipment purchase in Avivagen’s history • Purchase order represents more than 40% of previous fiscal year’s total volume Ottawa, ON / Business Wire/ April 23, 2021 / – Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen”), a life sciences corporation focused on developing and commercializing products for livestock, companion animal and …Read More
Avivagen Inc. to Issue Shares to holders of Debentures in Lieu of Annual Maintenance Fee
Ottawa, ON /Business Wire/ April 9, 2021/ – Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that a total of 3,931 common shares will be issued at the rate of $0.58 per share to satisfy the maintenance fee of $2,280 owing in respect of the debentures issued on April 9, 2019. This issuance is …Read More
Avivagen Announces Results From Its Annual General Meeting April 8, 2021
Ottawa, ON / Business Wire / April 8, 2021 / – Avivagen Inc. (TSXV:VIV, OTCQB:VIVXF) (“Avivagen” or the “Corporation”) announces that at the Corporation’s Annual General Meeting (AGM) held today the Corporation’s shareholders voted to support all of the resolutions that came before the meeting. The resolutions included the reappointment of McGovern Hurley LLP as Avivagen’s …Read More
